Lọc theo danh mục
  • Năm xuất bản
    Xem thêm
  • Lĩnh vực
liên kết website
Lượt truy cập
 Lượt truy cập :  20,368,473
  • Công bố khoa học và công nghệ Việt Nam

76.29.53

Y học lâm sàng

Ngô Quý Châu(1), Trịnh Thị Hương

Giá trị của Streptokinase trong điều trị viêm mủ màng phổi

Value of intrapleural streptokinase in the treatment of empyema in Respiratory department - Bach Mai hospital

TC Nghiên cứu Y học

2012

3

101-107

0868-202X

Empyema is associated with significant complication and mortality. Intrapleural streptokinase has been used in empyemas with good success rate. Objectives of the study was to evaluate the efficacy and side effects of intrapleural streptokinase in the treatment of empyema. The results showed that the average duration of hospital stay, the average duration of chest tube were shorter in the intrapleural streptokinase group. Side effect: chest pain, fever, allegy were mild, hemothorax occurred 2 patients. In conclusion, intrapleural STK is safe and effective in the treatment of empyema, STK prevent pleural adhesions and reduce risks for surgery, reduce the average duration of hospital stay.

TTKHCNQG, CVv251